Navigation Links
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Date:8/5/2008

HALIFAX, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its vaccine platform. The specific patent, Vaccines with enhanced immune response and methods for their preparation, claims broad exclusivity that an effective, long-term immune response to treat a disease can be produced using a vaccine comprising of an antigen, an adjuvant, vesicles known as liposomes, and a hydrophobic carrier.

"We have a novel technology that enhances vaccines dramatically, so receiving patent approval is important in protecting our competitive advantage," commented Dr. Marc Mansour, Vice President R&D at IVT.

Securing broad patent coverage is part of IVT's strategy to maximize the market potential of its VacciMax(R) platform in the largest pharmaceutical markets in the world; including the US, Europe, Canada, Australia and Japan. The company's VacciMax(R) technology is based on a novel approach to the use of liposomes in an oil emulsion. IVT has discovered that liposomes, stabilized in the VacciMax(R) technology, significantly enhance antibody production, creating a more rapid immune response, following a single vaccination. The responses are also long lasting, without requiring booster immunizations.

"The issuance of the patent in Japan complements the US and European patents for our vaccine platform technology," said Dr Randal Chase, President and CEO of IVT. "We are watching the growth of the Asian market, and patent coverage in Japan is an important step in contributing to the wide reach of our vaccine products."

About IVT

ImmunoVaccine Technologies Inc. is a private, clinical-stage, vaccine development company. Through its own biotech research, patented VacciMax(R) and DepoVax(TM) technologies, and collaborations with partners, IVT creates vaccines with the potential to help save and improve lives around the world.

'/>"/>
SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
2. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
3. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
4. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
5. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
6. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
7. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
8. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
9. Local officials move toward monitoring nanotechnologies
10. VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
11. China Medical Technologies Adjusts Conversion Rate of Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... August 21, 2014 Pursuit Solutions ... optimization technology and services for Life Sciences sales ... Pharma’s Use of New Commercial Sales Models” by ... Analytics. , The article examines some innovative models ... are being tested in the pharmaceutical market. Robinson ...
(Date:8/21/2014)... 21, 2014 On Wednesday of last week ... use Redox Signaling molecules, became available for purchase in Australia ... "The way that RENU 28 works is, if you think ... of the rate of cellular renewal within your body. If ... of that rate of cellular renewal. What RENU 28 does ...
(Date:8/20/2014)... measuring vibrational motion of a single molecule with a ... a single molecule differs from the behaviour of larger ... the University of California, Irvine, where post-doctoral researcher Eero ... visiting fellow under professor Vartkess A. Apkarian, whose team ... by Professor Eric O. Potma. The results of the ...
(Date:8/20/2014)... Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: ... presenting at the Baird Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... Wednesday, Sept. 3, 2014. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2PAREXEL International To Present At Baird Healthcare Conference 2
... BSP Biological Signal Processing Ltd. ... the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), ... research study evaluating the performance of the company,s HyperQ ... and its results was accepted for publication in the ...
... , This release is available in German ... with the Max Planck Society and the German Cancer Research ... super-resolution STED (Stimulated Emission Depletion) microscopy. This gives Leica Microsystems ... into a commercial product and put it on the market. ...
... Md., Nov. 11, 2011 Spherix Incorporated (NASDAQ: ... therapy in diabetes, metabolic syndrome and atherosclerosis, and providers ... biotechnology and pharmaceutical companies -- today reported financial results ... 2011. Recent and Upcoming Highlights ...
Cached Biology Technology:Positive Clinical Study Results for BSP's HyperQ Technology 2Positive Clinical Study Results for BSP's HyperQ Technology 3Gated STED -- developing the next generation of super-resolution microscopes 2Spherix Announces Third Quarter Financial Results 2Spherix Announces Third Quarter Financial Results 3Spherix Announces Third Quarter Financial Results 4Spherix Announces Third Quarter Financial Results 5Spherix Announces Third Quarter Financial Results 6Spherix Announces Third Quarter Financial Results 7
(Date:8/20/2014)... Arizona State University, the Wellcome Trust Sanger Institute and ... isolated Mycobacterium pinnipedii from skeletons found in ... pathogen is a relative of the TB bacterium that ... today. These researchers assume that seals carried the pathogens ... sea lions was unexpected" comments Sebastien Gagneux, from the ...
(Date:8/20/2014)... Cancer Research UK scientists have discovered that acral melanomas ... Bob Marley,s death are genetically distinct from other more ... is external) published in the journal Pigment Cell & ... palms of the hands, soles of the feet, nail-beds and ... types of melanoma, it,s not caused by UV damage from ...
(Date:8/20/2014)... and plastic bags could one day be made out ... scientists are now reporting. The novel process they developed ... with its agricultural and plastic waste problems, appear in ... Ilker S. Bayer and colleagues at the Italian Institute ... growing. In 2012, its production reached 288 million tons ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2
... forks, researchers at Pacific Northwest National Laboratory have ... promises to meet or exceed current and emerging ... technique, called Quartz Laser Photo-Acoustic Sensing, or "QPAS," ... , PNNL, a Department of Energy national ...
... Rochester scientists, while investigating the two most frequent types ... to treatment that would take advantage of the mutations ... reported online this week in the journal Nature Structural ... human cells, co-authors Mingxuan Xia, Ph.D., and Hartmut Land, ...
... mutation that causes X-linked mental retardation for which there ... article to be published electronically on Tuesday, March 20, ... , Investigators F. Lucy Raymond (Cambridge Institute of Medical ... Tarpey (Wellcome Trust Sanger Institute, Hixton, UK) describe the ...
Cached Biology News:New sensor detects gaseous chemical weapon surrogates in 45 seconds 2Scientists uncover new target in cancer mutation puzzle 2Severe mental retardation gene mutation identified 2
... easy to use Ascent Software ... members of the Ascent microplate ... clear and easy-to-follow approach with ... and highly sophisticated data handling, ...
Roll of Mesh 5m x 25cm...
... The Beacon 2000 Fluorescence Polarization ... basic research and assay development. Standard ... Beacon 2000 System uses a quartz-halogen ... range of 360-700 nm. It accommodates ...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: